BRCA1/2基因突变不影响乳腺癌生育力保存候选者卵母细胞的体外成熟能力
本回顾性队列研究纳入2014年1月至2017年12月间329例接受未成熟卵母细胞体外成熟(IVM)的乳腺癌生育力保存候选者,比较BRCA突变组(n=52)与BRCA阴性组(n=277)的卵母细胞成熟率及冷冻MII卵母细胞数。结果显示两组获卵数、IVM成熟率及冷冻MII卵母细胞数均无显著差异,提示BRCA1/2基因突变不影响卵母细胞体外成熟能力。
要点
- BRCA突变组与BRCA阴性组的IVM成熟率分别为67±24%与62±23%,无显著差异(P=0.2)。
- 两组冷冻MII卵母细胞数分别为5.1±3.8与6.1±5.1,无显著差异(P=0.1)。
- 作者认为BRCA突变虽改变DNA修复机制,但似乎不损害卵母细胞体外成熟能力。
核心结论
- BRCA1/2基因突变不影响乳腺癌生育力保存候选者卵母细胞的体外成熟能力。
研究设计与样本
- 回顾性队列研究,纳入2014年1月至2017年12月间329例接受IVM的乳腺癌生育力保存候选者。
- 纳入标准为年龄18-40岁、双侧卵巢存在、无化疗史、已进行BRCA1/2突变检测。
主要发现
- BRCA突变组(n=52)与BRCA阴性组(n=277)的年龄分别为31.7±3.9岁与32.3±3.8岁(P=0.3),BMI分别为23.4±4.7与22.6±3.7 kg/m2(P=0.3)。
- 两组窦卵泡计数分别为20.5±11.4与21.7±12.1个(P=0.5),血清AMH水平分别为3.6±2.9与4.1±3.6 ng/ml(P=0.3)。
- 两组获卵母细胞复合体数分别为8.9±6.9与9.9±8.1个(P=0.5),IVM成熟率分别为67±24%与62±23%(P=0.2)。
- 两组冷冻MII卵母细胞数分别为5.1±3.8与6.1±5.1个(P=0.1)。
临床怎么用
- 作者认为BRCA突变虽已知改变DNA修复机制,但似乎不损害卵母细胞体外成熟能力。
局限性
- 鉴于该突变发生率低,这些初步发现需进一步多中心研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are the maturation rates of oocytes recovered from small antral follicles different between breast cancer patients presenting with or without a BRCA 1/2 gene mutation? SUMMARY ANSWER: BRCA 1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. WHAT IS KNOWN ALREADY: Mutations in the BRCA1 and BRCA2 genes are associated with an increased risk for developing breast and ovarian cancer. Controversy exists about fertility and ovarian reserve in BRCA mutation carriers. Studies suggest that these patients may have low ovarian reserve and poor response to ovarian stimulation. The impaired ability of the mutated BRCA gene to repair double-strand breaks in DNA may prompt oocyte aging, apoptosis and meiotic errors. IVM of oocytes retrieved at germinal vesicle stage, followed by vitrification of metaphase II (MII) oocytes has recently emerged as an option for young women seeking fertility preservation, when ovarian stimulation is unfeasible. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study involving 329 breast cancer candidates for fertility preservation using IVM between January 2014 and December 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: Inclusion criteria were: age 18-40 years; two ovaries present; no history of chemotherapy; test for BRCA 1/2 mutations performed. Before immature oocyte retrieval, all follicles measuring 2-9 mm in diameter were precisely counted on both ovaries and serum anti-Müllerian hormone (AMH) was measured irrespective of the phase of the cycle. Number of cumulus oocyte complexes (COC) retrieved, maturation rate and number of MII oocytes cryopreserved were compared according to BRCA mutation status. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, BRCA-mutated women (n = 52) and BRCA-negative women (n = 277) were comparable in terms of age (31.7 ± 3.9 versus 32.3 ± 3.8 years, respectively, P = 0.3), BMI (23.4 ± 4.7 versus 22.6 ± 3.7 kg/m2, respectively, P = 0.3) and ovarian reserve tests (antral follicle count: 20.5 ± 11.4 versus 21.7 ± 12.1 follicles, P = 0.5; serum AMH levels: 3.6 ± 2.9 versus 4.1 ± 3.6 ng/ml, P = 0.3, respectively). The number of COCs retrieved did not differ significantly between both groups (8.9 ± 6.9 versus 9.9 ± 8.1 oocytes, P = 0.5). After similar IVM rates (67 ± 24 versus 62 ± 23%, P = 0.2), the number of MII oocytes cryopreserved was similar in patients presenting BRCA mutation or not (5.1 ± 3.8 versus 6.1 ± 5.1, P = 0.1, respectively). LIMITATIONS, REASONS FOR CAUTION: Given the low incidence of the mutation, these preliminary findings should be confirmed by further multi-center studies. WIDER IMPLICATIONS OF THE FINDINGS: Although BRCA mutations are known to alter DNA repair mechanism, it does not seem to impair oocyte capacity to mature in vitro. STUDY FUNDING/COMPETING INTEREST(S): None.
引用
- Grynberg M, Dagher Hayeck B, Papanikolaou EG, et al. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro. Hum Reprod. 2019. PMID: 30561604. doi:10.1093/humrep/dey358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。